{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:40:48Z","timestamp":1776418848767,"version":"3.51.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11136-025-03891-5","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T12:59:40Z","timestamp":1737118780000},"page":"1069-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of patient-reported symptoms with multi-item patient-reported outcome measures of fatigue, anxiety, and depression in the clinical care of women undergoing chemotherapy for early breast cancer"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2974-480X","authenticated-orcid":false,"given":"Kirsten A.","family":"Nyrop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison M.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coral H.","family":"Aman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyman B.","family":"Muss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce B.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"issue":"9","key":"3891_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnci\/dju244","volume":"106","author":"E Basch","year":"2014","unstructured":"Basch, E., Reeve, B. B., Mitchell, S. A., et al. (2014). Development of the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute, 106(9), 1\u201311.","journal-title":"Journal of the National Cancer Institute"},{"issue":"8","key":"3891_CR2","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","volume":"1","author":"AC Dueck","year":"2015","unstructured":"Dueck, A. C., Mendoza, T. R., Mitchell, S. A., et al. (2015). Validity and reliability of the us national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). JAMA Oncology, 1(8), 1051\u20131059. https:\/\/doi.org\/10.1001\/jamaoncol.2015.2639","journal-title":"JAMA Oncology"},{"issue":"8","key":"3891_CR3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/jco.2014.57.9334","volume":"33","author":"M Di Maio","year":"2015","unstructured":"Di Maio, M., Gallo, C., Leighl, N. B., et al. (2015). Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomized trials. Journal of Clinical Oncology, 33(8), 910\u2013915. https:\/\/doi.org\/10.1200\/jco.2014.57.9334","journal-title":"Journal of Clinical Oncology"},{"issue":"13","key":"3891_CR4","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1002\/cncr.32898","volume":"126","author":"KA Nyrop","year":"2020","unstructured":"Nyrop, K. A., Deal, A. M., Reeve, B. B., Basch, E., Chen, Y. T., Park, J. H., Shachar, S. S., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., & Jolly, T. A. (2020). Congruence of patient-and clinician-reported toxicity in women receiving chemotherapy for early breast cancer. Cancer, 126(13), 3084\u20133093.","journal-title":"Cancer"},{"issue":"7","key":"3891_CR5","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/cncr.32175","volume":"127","author":"KA Nyrop","year":"2019","unstructured":"Nyrop, K. A., Deal, A. M., Reeder-Hayes, K. E., et al. (2019). Patient and clinician-reported chemotherapy-induced peripheral neuropathy (CIPN) in early breast cancer: Current clinical practice. Cancer, 127(7), 2945\u20132954.","journal-title":"Cancer"},{"issue":"6","key":"3891_CR6","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1097\/NCC.0b013e318269040f","volume":"36","author":"C Xiao","year":"2013","unstructured":"Xiao, C., Polomano, R., & Bruner, D. W. (2013). Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs. Nov-Dec, 36(6), E1-e16. https:\/\/doi.org\/10.1097\/NCC.0b013e318269040f","journal-title":"Cancer Nurs. Nov-Dec"},{"issue":"8","key":"3891_CR7","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00520-016-3297-9","volume":"24","author":"TM Atkinson","year":"2016","unstructured":"Atkinson, T. M., Ryan, S. J., Bennett, A. V., et al. (2016). The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): A systematic review. Supportive Care in Cancer, 24(8), 3669\u20133676. https:\/\/doi.org\/10.1007\/s00520-016-3297-9","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"3891_CR8","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jpainsymman.2021.07.031","volume":"63","author":"B Langlais","year":"2022","unstructured":"Langlais, B., Mazza, G. L., Thanarajasingam, G., et al. (2022). Evaluating treatment tolerability using the toxicity index with patient-reported outcomes data. Journal of Pain and Symptom Management, 63(2), 311\u2013320. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.07.031","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"3891_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11136-015-1099-z","volume":"25","author":"D Kyte","year":"2016","unstructured":"Kyte, D., Reeve, B. B., Efficace, F., et al. (2016). International society for quality of life research commentary on the draft european medicines agency reflection paper on the use of patient-reported outcome (PRO) measures in oncology studies. Quality of Life Research, 25(2), 359\u2013362. https:\/\/doi.org\/10.1007\/s11136-015-1099-z","journal-title":"Quality of Life Research"},{"key":"3891_CR10","doi-asserted-by":"publisher","unstructured":"Basch E. The rationale for collecting patient-reported symptoms during routine chemotherapy. American Society of Clinical Oncology educational book \/ ASCO American Society of Clinical Oncology Meeting. https:\/\/doi.org\/10.14694\/EdBook_AM.2014.34.161","DOI":"10.14694\/EdBook_AM.2014.34.161"},{"issue":"12","key":"3891_CR11","doi-asserted-by":"publisher","first-page":"e230157","DOI":"10.57264\/cer-2023-0157","volume":"12","author":"E Basch","year":"2023","unstructured":"Basch, E., Hudson, K., & Rocque, G. (2023). Implementation of electronic patient-reported outcomes for symptom monitoring during cancer treatment: The importance of getting it right. J Comp Eff Res., 12(12), e230157. https:\/\/doi.org\/10.57264\/cer-2023-0157","journal-title":"J Comp Eff Res."},{"issue":"1","key":"3891_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.13063\/2327-9214.1169","volume":"3","author":"A Stover","year":"2015","unstructured":"Stover, A., Irwin, D. E., Chen, R. C., et al. (2015). Integrating patient-reported outcome measures into routine cancer care: Cancer patients\u2019 and clinicians\u2019 perceptions of acceptability and value. EGEMS (Washington, DC)., 3(1), 1169. https:\/\/doi.org\/10.13063\/2327-9214.1169","journal-title":"EGEMS (Washington, DC)."},{"key":"3891_CR13","doi-asserted-by":"crossref","unstructured":"Cella D, Lai J-s, Chang C-H, Peterman A, Stavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer. 2002;94:528\u2013538.","DOI":"10.1002\/cncr.10245"},{"issue":"2","key":"3891_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jgo.2018.08.009","volume":"10","author":"M Pergolotti","year":"2019","unstructured":"Pergolotti, M., Langer, M. M., Deal, A. M., Muss, H. B., Nyrop, K., & Williams, G. (2019). Mental status evaluation in older adults with cancer: Development of the mental health index-13. Journal of geriatric oncology., 10(2), 241\u2013245. https:\/\/doi.org\/10.1016\/j.jgo.2018.08.009","journal-title":"Journal of geriatric oncology."},{"issue":"6","key":"3891_CR15","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/cncr.33329","volume":"127","author":"KA Nyrop","year":"2021","unstructured":"Nyrop, K. A., Deal, A. M., Chen, Y. T., Reeve, B. B., Basch, E. M., Wood, W. A., Shachar, S. S., Carey, L. A., Reeder-Hayes, K. E., Dees, E. C., & Jolly, T. A. (2021). Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer. Cancer, 127(6), 957\u2013967.","journal-title":"Cancer"},{"issue":"1","key":"3891_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s00520-023-08275-4","volume":"32","author":"KA Nyrop","year":"2023","unstructured":"Nyrop, K. A., Page, A., Deal, A. M., et al. (2023). Association of self-directed walking with toxicity moderation during chemotherapy for the treatment of early breast cancer. Supportive Care in Cancer, 32(1), 68. https:\/\/doi.org\/10.1007\/s00520-023-08275-4","journal-title":"Supportive Care in Cancer"},{"key":"3891_CR17","doi-asserted-by":"publisher","unstructured":"Nyrop KA, Deal AM, Chen YT, Reeve BB. 2020 Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer. https:\/\/doi.org\/10.1002\/cncr.33329","DOI":"10.1002\/cncr.33329"},{"issue":"1","key":"3891_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1740774520975120","volume":"18","author":"E Basch","year":"2021","unstructured":"Basch, E., Becker, C., Rogak, L. J., et al. (2021). Composite grading algorithm for the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Clinical Trials, 18(1), 104\u2013114. https:\/\/doi.org\/10.1177\/1740774520975120","journal-title":"Clinical Trials"},{"issue":"1","key":"3891_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s41687-022-00508-0","volume":"6","author":"D Cella","year":"2022","unstructured":"Cella, D., Lenderking, W. R., Chongpinitchai, P., et al. (2022). Functional assessment of chronic illness therapy-fatigue is a reliable and valid measure in patients with active ankylosing spondylitis. J Patient Rep Outcomes, 6(1), 100. https:\/\/doi.org\/10.1186\/s41687-022-00508-0","journal-title":"J Patient Rep Outcomes"},{"issue":"5","key":"3891_CR20","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1037\/0022-006X.51.5.730","volume":"51","author":"CT Veit","year":"1983","unstructured":"Veit, C. T., & Ware, J. E., Jr. (1983). The structure of psychological distress and well-being in general populations. Journal of Consulting and Clinical Psychology, 51(5), 730\u2013742.","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"3891_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2018.08.009","author":"M Pergolotti","year":"2018","unstructured":"Pergolotti, M., Langer, M. M., Deal, A. M., Muss, H. B., Nyrop, K., & Williams, G. (2018). Mental status evaluation in older adults with cancer: Development of the mental health index-13. Journal of Geriatric Oncology. https:\/\/doi.org\/10.1016\/j.jgo.2018.08.009","journal-title":"Journal of Geriatric Oncology"},{"issue":"1","key":"3891_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","volume":"112","author":"J Cohen","year":"1992","unstructured":"Cohen, J. (1992). A power primer. Psych Bulletin, 112(1), 155\u2013159.","journal-title":"Psych Bulletin"},{"issue":"3","key":"3891_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jpainsymman.2018.05.017","volume":"56","author":"GA Taarnhoj","year":"2018","unstructured":"Taarnhoj, G. A., Kennedy, F. R., Absolom, K. L., et al. (2018). Comparison of EORTC QLQ-C30 and PRO-CTCAE Questionnaires on Six Symptom Items. Journal of Pain and Symptom Management, 56(3), 421\u2013429. https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.05.017","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"3891_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s41687-021-00377-z","volume":"5","author":"R Knoerl","year":"2021","unstructured":"Knoerl, R., Mazzola, E., Mitchell, S. A., et al. (2021). Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors. Journal Patient Rep Outcomes., 5(1), 101. https:\/\/doi.org\/10.1186\/s41687-021-00377-z","journal-title":"Journal Patient Rep Outcomes."},{"key":"3891_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkaa067","author":"R Sedhom","year":"2020","unstructured":"Sedhom, R., Ferrell, B., Ruel, N., Koczywas, M., Chung, V., & Smith, T. J. (2020). Using patient-reported outcomes to describe the patient experience on phase i clinical trials. JNCI Cancer Spectrum. https:\/\/doi.org\/10.1093\/jncics\/pkaa067","journal-title":"JNCI Cancer Spectrum"},{"key":"3891_CR26","doi-asserted-by":"publisher","unstructured":"Lee MK, Schalet BD, Cella D, et al. 2020 Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Patient Rep Outcomes. Dec 4(1):106. https:\/\/doi.org\/10.1186\/s41687-020-00271-0","DOI":"10.1186\/s41687-020-00271-0"},{"issue":"3","key":"3891_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cllc.2019.11.015","volume":"21","author":"LE Steffen McLouth","year":"2020","unstructured":"Steffen McLouth, L. E., Lycan, T. W., Jr., Levine, B. J., et al. (2020). Patient-reported outcomes from patients receiving immunotherapy or chemoimmunotherapy for metastatic non-small-cell lung cancer in clinical practice. Clinical Lung Cancer, 21(3), 255-263.e4. https:\/\/doi.org\/10.1016\/j.cllc.2019.11.015","journal-title":"Clinical Lung Cancer"},{"issue":"9","key":"3891_CR28","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1002\/cam4.2958","volume":"9","author":"GA Taarnh\u00f8j","year":"2020","unstructured":"Taarnh\u00f8j, G. A., Johansen, C., Lindberg, H., Basch, E., Dueck, A., & Pappot, H. (2020). Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease. Cancer Medicine, 9(9), 3078\u20133087. https:\/\/doi.org\/10.1002\/cam4.2958","journal-title":"Cancer Medicine"},{"issue":"1","key":"3891_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10549-017-4565-1","volume":"168","author":"KA Nyrop","year":"2018","unstructured":"Nyrop, K. A., Deal, A. M., Choi, S. K., et al. (2018). Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer. Breast Cancer Research and Treatment, 168(1), 43\u201355. https:\/\/doi.org\/10.1007\/s10549-017-4565-1","journal-title":"Breast Cancer Research and Treatment"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-03891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-025-03891-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-03891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:40:30Z","timestamp":1744224030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-025-03891-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1007\/s11136-025-03891-5","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]},"assertion":[{"value":"5 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest with respect to the research, authorship, and\/pr publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}